Bengaluru-based medical technology startup Cureous Labs has raised Rs 1.66 crore in a seed round led by Inflection Point Ventures (IPV), with participation from Anthill Ventures.
The proceeds will be used to manufacture the first batch of its flagship product Eturnal, build inventory, expand its sales and business development team, launch its first disinfection centre, and complete product safety testing and certifications.
Cureous Labs also plans to expand its portfolio for B2B customers in India.
Founded by Asish Mohandas, Cureous Labs develops…








